Saliva-based cancer risk test 'SalivaChecker®' evolves into a room-temperature kit. Held a discussion on the 'future of cancer screening' with partner Nippon Life Insurance.
NQ Score
0/100
N1 Content Completeness
6
AI Summary (NQ-processed)
SalivaTech's 'SalivaChecker', a cancer risk test using saliva, has evolved into a kit that can be stored at room temperature. A discussion with Nippon Life Insurance was also held.
AI Analysis
Frequently Asked Questions
- Q: What is the name of the saliva-based cancer risk test mentioned in the article?
- A: The saliva-based cancer risk test mentioned in the article is named SalivaChecker®.
- Q: Which bio-venture developed the cancer risk test SalivaChecker?
- A: The bio-venture that developed SalivaChecker is SalivaTech, which originated from the Institute for Advanced Biosciences at Keio University.
- Q: When did the sales of the SalivaChecker cancer test begin?
- A: The sales of the SalivaChecker cancer test began in January 2017.
- Q: How much saliva is needed for the SalivaChecker cancer test?
- A: The SalivaChecker cancer test requires only one drop of saliva to test for cancer.
- Q: What are the backgrounds of the CEO and CTO of SalivaTech?
- A: The CEO is from the First Department of Surgery, Tohoku University, and the CTO is a Professor at Tokyo Medical University and Specially Appointed Professor at Keio University.